Similar 5-Year Survival in Transfemoral and Transapical TAVI Patients: A Single-Center Experience

Transapical transcatheter aortic valve implantation (TA-TAVI) is generally considered to be associated with increased morbidity and mortality compared with transfemoral transcatheter aortic valve implantation TAVI (TF-TAVI). We aimed to compare different patient risk profiles, access-related complic...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Bioengineering (Basel) Ročník 10; číslo 2; s. 156
Hlavní autoři:	Mork, Constantin, Twerenbold, Raphael, Gahl, Brigitta, Eckstein, Friedrich, Jeger, Raban, Kaiser, Christoph, Reuthebuch, Oliver
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland MDPI AG 24.01.2023 MDPI
Témata:	Aorta Aortic stenosis Aortic valve aortic valve replacement Bioengineering Bleeding Calcification Cardiology Cardiovascular disease Chronic obstructive pulmonary disease Coronary vessels Ethics Heart valves Implantation Interdisciplinary aspects Medical personnel Morbidity Mortality Patients Physiological aspects Prostheses Risk assessment Risk factors Standard deviation Statistical analysis Stenosis Surgeons Survival transcatheter Values Variables Weighting Germany United States > US Switzerland aortic valve replacement mortality transcatheter
ISSN:	2306-5354, 2306-5354
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Transapical transcatheter aortic valve implantation (TA-TAVI) is generally considered to be associated with increased morbidity and mortality compared with transfemoral transcatheter aortic valve implantation TAVI (TF-TAVI). We aimed to compare different patient risk profiles, access-related complications, and long-term survival using inverse probability treatment weighting. This is a retrospective, single-center analysis of 925 consecutive patients with aortic valve stenosis undergoing TF-TAVI (n = 802) or TA-TAVI (n = 123) at the University Hospital Basel, Switzerland, as a single procedure between September 2011 and August 2020. Baseline characteristics revealed a higher perioperative risk as reflected in the EuroSCORE II (geometric mean 2.3 (95% confidence interval (CI) 2.2 to 2.4) vs. 3.7 (CI 3.1 to 4.5); before inverse probability of treatment weighting (IPTW) p < 0.001) in the transfemoral than in the transapical group, respectively. After 30 days, TF-TAVI patients had a higher incidence of any bleeding than TA-TAVI patients (TF-TAVI n = 146 vs. TA-TAVI n = 15; weighted hazard ratio (HR) 0.52 (0.29 to 0.95); p = 0.032). After 5 years, all-cause mortality did not differ between the two groups (TF-TAVI n = 162 vs. TA-TAVI n = 45; weighted HR 1.31, (0.92 to 1.88); p = 0.138). With regard to our data, we could demonstrate, despite a higher perioperative risk, the short- and long-term safety and efficacy of the transapical approach for TAVI therapies. Though at higher perioperative risk, transapically treated patients suffered from less bleeding or vascular complications than transfemorally treated patients. It is of utmost interest that 5-year mortality did not differ between the groups.
AbstractList	Transapical transcatheter aortic valve implantation (TA-TAVI) is generally considered to be associated with increased morbidity and mortality compared with transfemoral transcatheter aortic valve implantation TAVI (TF-TAVI). We aimed to compare different patient risk profiles, access-related complications, and long-term survival using inverse probability treatment weighting. This is a retrospective, single-center analysis of 925 consecutive patients with aortic valve stenosis undergoing TF-TAVI (n = 802) or TA-TAVI (n = 123) at the University Hospital Basel, Switzerland, as a single procedure between September 2011 and August 2020. Baseline characteristics revealed a higher perioperative risk as reflected in the EuroSCORE II (geometric mean 2.3 (95% confidence interval (CI) 2.2 to 2.4) vs. 3.7 (CI 3.1 to 4.5); before inverse probability of treatment weighting (IPTW) p < 0.001) in the transfemoral than in the transapical group, respectively. After 30 days, TF-TAVI patients had a higher incidence of any bleeding than TA-TAVI patients (TF-TAVI n = 146 vs. TA-TAVI n = 15; weighted hazard ratio (HR) 0.52 (0.29 to 0.95); p = 0.032). After 5 years, all-cause mortality did not differ between the two groups (TF-TAVI n = 162 vs. TA-TAVI n = 45; weighted HR 1.31, (0.92 to 1.88); p = 0.138). With regard to our data, we could demonstrate, despite a higher perioperative risk, the short- and long-term safety and efficacy of the transapical approach for TAVI therapies. Though at higher perioperative risk, transapically treated patients suffered from less bleeding or vascular complications than transfemorally treated patients. It is of utmost interest that 5-year mortality did not differ between the groups. Transapical transcatheter aortic valve implantation (TA-TAVI) is generally considered to be associated with increased morbidity and mortality compared with transfemoral transcatheter aortic valve implantation TAVI (TF-TAVI). We aimed to compare different patient risk profiles, access-related complications, and long-term survival using inverse probability treatment weighting. This is a retrospective, single-center analysis of 925 consecutive patients with aortic valve stenosis undergoing TF-TAVI (n = 802) or TA-TAVI (n = 123) at the University Hospital Basel, Switzerland, as a single procedure between September 2011 and August 2020. Baseline characteristics revealed a higher perioperative risk as reflected in the EuroSCORE II (geometric mean 2.3 (95% confidence interval (CI) 2.2 to 2.4) vs. 3.7 (CI 3.1 to 4.5); before inverse probability of treatment weighting (IPTW) p < 0.001) in the transfemoral than in the transapical group, respectively. After 30 days, TF-TAVI patients had a higher incidence of any bleeding than TA-TAVI patients (TF-TAVI n = 146 vs. TA-TAVI n = 15; weighted hazard ratio (HR) 0.52 (0.29 to 0.95); p = 0.032). After 5 years, all-cause mortality did not differ between the two groups (TF-TAVI n = 162 vs. TA-TAVI n = 45; weighted HR 1.31, (0.92 to 1.88); p = 0.138). With regard to our data, we could demonstrate, despite a higher perioperative risk, the short- and long-term safety and efficacy of the transapical approach for TAVI therapies. Though at higher perioperative risk, transapically treated patients suffered from less bleeding or vascular complications than transfemorally treated patients. It is of utmost interest that 5-year mortality did not differ between the groups.Transapical transcatheter aortic valve implantation (TA-TAVI) is generally considered to be associated with increased morbidity and mortality compared with transfemoral transcatheter aortic valve implantation TAVI (TF-TAVI). We aimed to compare different patient risk profiles, access-related complications, and long-term survival using inverse probability treatment weighting. This is a retrospective, single-center analysis of 925 consecutive patients with aortic valve stenosis undergoing TF-TAVI (n = 802) or TA-TAVI (n = 123) at the University Hospital Basel, Switzerland, as a single procedure between September 2011 and August 2020. Baseline characteristics revealed a higher perioperative risk as reflected in the EuroSCORE II (geometric mean 2.3 (95% confidence interval (CI) 2.2 to 2.4) vs. 3.7 (CI 3.1 to 4.5); before inverse probability of treatment weighting (IPTW) p < 0.001) in the transfemoral than in the transapical group, respectively. After 30 days, TF-TAVI patients had a higher incidence of any bleeding than TA-TAVI patients (TF-TAVI n = 146 vs. TA-TAVI n = 15; weighted hazard ratio (HR) 0.52 (0.29 to 0.95); p = 0.032). After 5 years, all-cause mortality did not differ between the two groups (TF-TAVI n = 162 vs. TA-TAVI n = 45; weighted HR 1.31, (0.92 to 1.88); p = 0.138). With regard to our data, we could demonstrate, despite a higher perioperative risk, the short- and long-term safety and efficacy of the transapical approach for TAVI therapies. Though at higher perioperative risk, transapically treated patients suffered from less bleeding or vascular complications than transfemorally treated patients. It is of utmost interest that 5-year mortality did not differ between the groups. Transapical transcatheter aortic valve implantation (TA-TAVI) is generally considered to be associated with increased morbidity and mortality compared with transfemoral transcatheter aortic valve implantation TAVI (TF-TAVI). We aimed to compare different patient risk profiles, access-related complications, and long-term survival using inverse probability treatment weighting. This is a retrospective, single-center analysis of 925 consecutive patients with aortic valve stenosis undergoing TF-TAVI (n = 802) or TA-TAVI (n = 123) at the University Hospital Basel, Switzerland, as a single procedure between September 2011 and August 2020. Baseline characteristics revealed a higher perioperative risk as reflected in the EuroSCORE II (geometric mean 2.3 (95% confidence interval (CI) 2.2 to 2.4) vs. 3.7 (CI 3.1 to 4.5); before inverse probability of treatment weighting (IPTW) < 0.001) in the transfemoral than in the transapical group, respectively. After 30 days, TF-TAVI patients had a higher incidence of any bleeding than TA-TAVI patients (TF-TAVI n = 146 vs. TA-TAVI n = 15; weighted hazard ratio (HR) 0.52 (0.29 to 0.95); = 0.032). After 5 years, all-cause mortality did not differ between the two groups (TF-TAVI n = 162 vs. TA-TAVI n = 45; weighted HR 1.31, (0.92 to 1.88); = 0.138). With regard to our data, we could demonstrate, despite a higher perioperative risk, the short- and long-term safety and efficacy of the transapical approach for TAVI therapies. Though at higher perioperative risk, transapically treated patients suffered from less bleeding or vascular complications than transfemorally treated patients. It is of utmost interest that 5-year mortality did not differ between the groups.
Audience	Academic
Author	Mork, Constantin Gahl, Brigitta Jeger, Raban Reuthebuch, Oliver Eckstein, Friedrich Twerenbold, Raphael Kaiser, Christoph
AuthorAffiliation	1 Department of Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, 4031 Basel, Switzerland 2 Department of Cardiac Surgery, University Hospital Basel, 4031 Basel, Switzerland 6 Department of Cardiology, University Hospital Basel, 4031 Basel, Switzerland 4 Department of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany 3 University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany 5 Department of Cardiology, Triemli Hospital Zurich, 8063 Zurich, Switzerland
AuthorAffiliation_xml	– name: 3 University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany – name: 4 Department of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany – name: 2 Department of Cardiac Surgery, University Hospital Basel, 4031 Basel, Switzerland – name: 5 Department of Cardiology, Triemli Hospital Zurich, 8063 Zurich, Switzerland – name: 1 Department of Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, 4031 Basel, Switzerland – name: 6 Department of Cardiology, University Hospital Basel, 4031 Basel, Switzerland
Author_xml	– sequence: 1 givenname: Constantin orcidid: 0000-0001-7928-850X surname: Mork fullname: Mork, Constantin – sequence: 2 givenname: Raphael orcidid: 0000-0003-3814-6542 surname: Twerenbold fullname: Twerenbold, Raphael – sequence: 3 givenname: Brigitta surname: Gahl fullname: Gahl, Brigitta – sequence: 4 givenname: Friedrich surname: Eckstein fullname: Eckstein, Friedrich – sequence: 5 givenname: Raban orcidid: 0000-0003-1290-5491 surname: Jeger fullname: Jeger, Raban – sequence: 6 givenname: Christoph surname: Kaiser fullname: Kaiser, Christoph – sequence: 7 givenname: Oliver orcidid: 0000-0003-1386-0686 surname: Reuthebuch fullname: Reuthebuch, Oliver
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/36829650$$D View this record in MEDLINE/PubMed
BookMark	eNqFUm1rFDEQXqRia-1fKAt-8cvWydu-iAjHUfWgoHCn4KeQzU7OlL3kzO4d9d8716u1VwqSQDKTZ57MMzwvs6MQA2bZOYMLIRp42_qIYekDYvJhyQA4MFU-y064gLJQQsmjB_fj7GwYrgGACa54KV9kx6KseVMqOMnM3K98b1Kuih9Ix3yTtn5r-tyHfJFMGByuYqLYhG6fMGtvKV5Mvs_yr2b0GMbhXT7J59RKj8WUYkz55c2amsNg8VX23Jl-wLO78zT79vFyMf1cXH35NJtOrgqrKjUWVoCsy1Y2negq2bRtLWQjmGjqrjTKVULWABYB29pC6QRzVSuxYwZ4y7CuxWk22_N20VzrdfIrk37raLy-TcS01CaN3vaom9Z20DU10JbO8VZWkvO6dACuc3LH9WHPtd60K-wsaaIZHJAevgT_Uy_jVjeN4gw4Eby5I0jx1waHUa_8YLHvTcC4GTSvSE0F6rbv14-g13GTAo2KUBXxiYo3_1BLQwJ8cJH-tTtSPaHmGWGYItTFEyhaHa68JRM5T_mDgvOHQu8V_jUIAco9wKY4DAndPYSB3plRP21GKnz_qND6kewSdwPz_f_K_wDBsufv
CitedBy_id	crossref_primary_10_1016_j_jscai_2024_102514
Cites_doi	10.1055/s-0035-1552980 10.1093/ejcts/ezy363 10.1161/CIRCINTERVENTIONS.113.000761 10.1056/NEJMoa1814052 10.4244/EIJV10I8A166 10.1002/sim.6607 10.1016/j.jtcvs.2006.01.026 10.1016/j.jtcvs.2012.09.002 10.1056/NEJMoa1114705 10.1080/00273171.2011.568786 10.1016/j.jtcvs.2018.04.104 10.1016/j.jacc.2003.11.026 10.1161/CIRCULATIONAHA.114.012525 10.1016/j.jcin.2011.03.019 10.4244/EIJ-D-18-01048 10.1093/eurheartj/ehab395 10.1016/j.athoracsur.2013.09.088 10.4244/EIJV8I12A209 10.1111/joic.12084 10.1093/eurheartj/ehx391 10.1161/CIRCULATIONAHA.114.013947 10.1186/s13019-017-0638-9 10.1161/CIRCULATIONAHA.109.907402 10.1161/01.CIR.0000047200.36165.B8 10.1056/NEJMoa1816885
ContentType	Journal Article
Copyright	COPYRIGHT 2023 MDPI AG 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 by the authors. 2023
Copyright_xml	– notice: COPYRIGHT 2023 MDPI AG – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 by the authors. 2023
DBID	AAYXX CITATION NPM 8FE 8FG 8FH ABJCF ABUWG AFKRA AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO GNUQQ HCIFZ L6V LK8 M7P M7S PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS PTHSS 7X8 5PM DOA
DOI	10.3390/bioengineering10020156
DatabaseName	CrossRef PubMed ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Materials Science & Engineering Collection ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Technology Collection Natural Science Collection ProQuest One Community College ProQuest Central Korea ProQuest Central Student SciTech Premium Collection ProQuest Engineering Collection ProQuest Biological Science Collection Biological Science Database Engineering Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef PubMed Publicly Available Content Database ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Engineering Collection Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) Engineering Collection Engineering Database ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Technology Collection Biological Science Database ProQuest SciTech Collection ProQuest One Academic UKI Edition Materials Science & Engineering Collection ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic
DatabaseTitleList	CrossRef MEDLINE - Academic Publicly Available Content Database PubMed
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Engineering
EISSN	2306-5354
ExternalDocumentID	oai_doaj_org_article_9bcd0d9809804ff2b4742286f00fdf48 PMC9952102 A742172915 36829650 10_3390_bioengineering10020156
Genre	Journal Article
GeographicLocations	Germany United States--US Switzerland
GeographicLocations_xml	– name: Germany – name: Switzerland – name: United States--US
GroupedDBID	53G 5VS 8FE 8FG 8FH AAFWJ AAYXX ABDBF ABJCF ACUHS ADBBV AFFHD AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BBNVY BCNDV BENPR BGLVJ BHPHI CCPQU CITATION GROUPED_DOAJ HCIFZ HYE IAO IHR INH ITC KQ8 L6V LK8 M7P M7S MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY PQGLB PROAC PTHSS RPM NPM ABUWG AZQEC DWQXO GNUQQ PKEHL PQEST PQQKQ PQUKI PRINS 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c575t-c30486b49d3d749bb834931398d6a5f734800ce0eb8c06f31f7b4ed1a02b1e883
IEDL.DBID	M7P
ISICitedReferencesCount	0
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000938390100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2306-5354
IngestDate	Fri Oct 03 12:46:04 EDT 2025 Tue Nov 04 02:06:35 EST 2025 Fri Sep 05 14:00:03 EDT 2025 Fri Jul 25 11:48:35 EDT 2025 Tue Nov 11 11:10:37 EST 2025 Tue Nov 04 18:37:19 EST 2025 Thu Jan 02 22:53:34 EST 2025 Tue Nov 18 22:22:57 EST 2025 Sat Nov 29 07:11:23 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	aortic valve replacement mortality transcatheter
Language	English
License	Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c575t-c30486b49d3d749bb834931398d6a5f734800ce0eb8c06f31f7b4ed1a02b1e883
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Both authors should be considered as first shared authors.
ORCID	0000-0003-3814-6542 0000-0001-7928-850X 0000-0003-1290-5491 0000-0003-1386-0686
OpenAccessLink	https://www.proquest.com/docview/2779523729?pq-origsite=%requestingapplication%
PMID	36829650
PQID	2779523729
PQPubID	2055440
ParticipantIDs	doaj_primary_oai_doaj_org_article_9bcd0d9809804ff2b4742286f00fdf48 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9952102 proquest_miscellaneous_2780070588 proquest_journals_2779523729 gale_infotracmisc_A742172915 gale_infotracacademiconefile_A742172915 pubmed_primary_36829650 crossref_primary_10_3390_bioengineering10020156 crossref_citationtrail_10_3390_bioengineering10020156
PublicationCentury	2000
PublicationDate	20230124
PublicationDateYYYYMMDD	2023-01-24
PublicationDate_xml	– month: 1 year: 2023 text: 20230124 day: 24
PublicationDecade	2020
PublicationPlace	Switzerland
PublicationPlace_xml	– name: Switzerland – name: Basel
PublicationTitle	Bioengineering (Basel)
PublicationTitleAlternate	Bioengineering (Basel)
PublicationYear	2023
Publisher	MDPI AG MDPI
Publisher_xml	– name: MDPI AG – name: MDPI
References	Blackman (ref_23) 2014; 27 Wenaweser (ref_24) 2014; 10 Popma (ref_6) 2019; 380 ref_14 Marcheix (ref_22) 2014; 97 Booth (ref_4) 2016; 85 Kappetein (ref_15) 2013; 145 Gilard (ref_12) 2012; 366 Furukawa (ref_13) 2018; 156 ref_19 Ludman (ref_11) 2015; 131 Cribier (ref_3) 2002; 106 Eltchaninoff (ref_20) 2013; 8 Austin (ref_17) 2011; 46 Reents (ref_18) 2019; 55 Reuthebuch (ref_25) 2015; 63 Bourantas (ref_27) 2019; 14 Blackstone (ref_10) 2015; 131 Mack (ref_8) 2019; 380 Vahanian (ref_1) 2022; 43 Ye (ref_9) 2006; 131 Cribier (ref_5) 2004; 43 Baumgartner (ref_7) 2017; 38 Otto (ref_2) 2021; 143 Hayashida (ref_26) 2011; 4 Austin (ref_16) 2015; 34 Thomas (ref_21) 2010; 122
References_xml	– volume: 63 start-page: 493 year: 2015 ident: ref_25 article-title: Transapical Transcatheter Aortic Valve Implantation Using the JenaValve: A One-Year Follow-Up publication-title: Thorac. Cardiovasc. Surg. doi: 10.1055/s-0035-1552980 – volume: 55 start-page: 744 year: 2019 ident: ref_18 article-title: Transfemoral versus Transapical Transcatheter Aortic Valve Implantation: A Single-Centre Experience publication-title: Eur. J. Cardio-Thorac. Surg. doi: 10.1093/ejcts/ezy363 – ident: ref_19 doi: 10.1161/CIRCINTERVENTIONS.113.000761 – volume: 380 start-page: 1695 year: 2019 ident: ref_8 article-title: Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1814052 – volume: 10 start-page: 982 year: 2014 ident: ref_24 article-title: Short-Term Clinical Outcomes among Patients Undergoing Transcatheter Aortic Valve Implantation in Switzerland: The Swiss TAVI Registry publication-title: EuroIntervention doi: 10.4244/EIJV10I8A166 – volume: 34 start-page: 3661 year: 2015 ident: ref_16 article-title: Moving towards Best Practice When Using Inverse Probability of Treatment Weighting (IPTW) Using the Propensity Score to Estimate Causal Treatment Effects in Observational Studies publication-title: Stat. Med. doi: 10.1002/sim.6607 – volume: 131 start-page: 1194 year: 2006 ident: ref_9 article-title: Transapical Aortic Valve Implantation in Humans publication-title: J. Thorac. Cardiovasc. Surg. doi: 10.1016/j.jtcvs.2006.01.026 – volume: 145 start-page: 6 year: 2013 ident: ref_15 article-title: Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation: The Valve Academic Research Consortium-2 Consensus Document publication-title: J. Thorac. Cardiovasc. Surg. doi: 10.1016/j.jtcvs.2012.09.002 – volume: 366 start-page: 1705 year: 2012 ident: ref_12 article-title: Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1114705 – volume: 46 start-page: 399 year: 2011 ident: ref_17 article-title: An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies publication-title: Multivar. Behav. Res. doi: 10.1080/00273171.2011.568786 – volume: 143 start-page: E72 year: 2021 ident: ref_2 article-title: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines publication-title: Circulation – volume: 156 start-page: 1825 year: 2018 ident: ref_13 article-title: Minimally Invasive versus Transapical versus Transfemoral Aortic Valve Implantation: A One-to-One-to-One Propensity Score–Matched Analysis publication-title: J. Thorac. Cardiovasc. Surg. doi: 10.1016/j.jtcvs.2018.04.104 – volume: 43 start-page: 698 year: 2004 ident: ref_5 article-title: Early Experience with Percutaneous Transcatheter Implantation of Heart Valve Prosthesis for the Treatment of End-Stage Inoperable Patients with Calcific Aortic Stenosis publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2003.11.026 – volume: 131 start-page: 1989 year: 2015 ident: ref_10 article-title: Propensity-Matched Comparisons of Clinical Outcomes after Transapical or Transfemoral Transcatheter Aortic Valve Replacement a Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.012525 – volume: 4 start-page: 851 year: 2011 ident: ref_26 article-title: Transfemoral Aortic Valve Implantation: New Criteria to Predict Vascular Complications publication-title: JACC Cardiovasc. Interv. doi: 10.1016/j.jcin.2011.03.019 – volume: 14 start-page: e1826 year: 2019 ident: ref_27 article-title: The Evolution of Device Technology in Transcatheter Aortic Valve Implantation publication-title: EuroIntervention doi: 10.4244/EIJ-D-18-01048 – volume: 43 start-page: 561 year: 2022 ident: ref_1 article-title: 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehab395 – volume: 85 start-page: 18 year: 2016 ident: ref_4 article-title: High Risk Aortic Valve Replacement – the Challenges of Multiple Treatment Strategies with an Evolving Technology publication-title: Ulster Med. J. – volume: 97 start-page: 22 year: 2014 ident: ref_22 article-title: Transapical versus Transfemoral Aortic Valve Implantation: A Multicenter Collaborative Study publication-title: Ann. Thorac. Surg. doi: 10.1016/j.athoracsur.2013.09.088 – volume: 8 start-page: 1362 year: 2013 ident: ref_20 article-title: The 2011-12 Pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: In-Hospital Results in 4,571 Patients publication-title: EuroIntervention doi: 10.4244/EIJV8I12A209 – volume: 27 start-page: 86 year: 2014 ident: ref_23 article-title: Do Outcomes from Transcatheter Aortic Valve Implantation Vary According to Access Route and Valve Type? The UK TAVI Registry publication-title: J. Interv. Cardiol. doi: 10.1111/joic.12084 – volume: 38 start-page: 2739 year: 2017 ident: ref_7 article-title: 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehx391 – volume: 131 start-page: 1181 year: 2015 ident: ref_11 article-title: Transcatheter Aortic Valve Implantation in the United Kingdom: Temporal Trends, Predictors of Outcome, and 6-Year Follow-up: A Report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.013947 – ident: ref_14 doi: 10.1186/s13019-017-0638-9 – volume: 122 start-page: 62 year: 2010 ident: ref_21 article-title: Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.907402 – volume: 106 start-page: 3006 year: 2002 ident: ref_3 article-title: Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description publication-title: Circulation doi: 10.1161/01.CIR.0000047200.36165.B8 – volume: 380 start-page: 1706 year: 2019 ident: ref_6 article-title: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1816885
SSID	ssj0001325264
Score	2.2151437
Snippet	Transapical transcatheter aortic valve implantation (TA-TAVI) is generally considered to be associated with increased morbidity and mortality compared with...
SourceID	doaj pubmedcentral proquest gale pubmed crossref
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source
StartPage	156
SubjectTerms	Aorta Aortic stenosis Aortic valve aortic valve replacement Bioengineering Bleeding Calcification Cardiology Cardiovascular disease Chronic obstructive pulmonary disease Coronary vessels Ethics Heart valves Implantation Interdisciplinary aspects Medical personnel Morbidity Mortality Patients Physiological aspects Prostheses Risk assessment Risk factors Standard deviation Statistical analysis Stenosis Surgeons Survival transcatheter Values Variables Weighting
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQxQEOiPIMtMhISJyi9dqOH70tFRVcqkpbUDlFfopIJVvtg9_PTJJuE4HUC1IuiceJ7Rl7ZpzxN4R8CIo55VQqjTMBfzOm0omcS21ViskoJ2zskk3o83NzdWUvRqm-MCashwfuB25mfYgsWsPgkjlzLzWiVqnMWI5Zdsd8weoZOVPd7orgFaj6_kiwAL9-5ptVukP4Q-BRPEQ80UYdaP_fS_NIN03jJkeK6OwpeTJYkHTRt_yQPEjtM_J4hCv4nLhl86sBl5VW5Q-QZLrcwYIAIkWblnbKKWN8Ldy7NvYP3A0yi14uvn-lFz3U6uaELugS3nedStwDTmt6h4v8gnw7-3x5-qUccimUAQyybRkEYut5aaOIWlrvjZBWgPlnonJVRowbxkJiyZvAVBbzrL1Mce4Y9_NkjHhJDtpVm14TqozPrkJgOp4lsMNXLGoblFXAHZ5UQarbMa3DADSO-S6ua3A4kBf1v3lRkNm-3k0PtXFvjU_Isj01QmV3D0CA6kGA6vsEqCAfkeE1TmhoZnDDuQToLEJj1QsgByvPzquCHE0oYSKGafGtyNTDQrCpudYWfH0gKMj7fTHWxOC2Nq12SGMQdaky0JZXvYTtuySU4Ras6ILoiexN-jwtaZufHUy4hQ-D-fjmfwzSW_KIg3WHe09cHpGD7XqXjsnD8HvbbNbvurn3B75uNWg priority: 102 providerName: Directory of Open Access Journals
Title	Similar 5-Year Survival in Transfemoral and Transapical TAVI Patients: A Single-Center Experience
URI	https://www.ncbi.nlm.nih.gov/pubmed/36829650 https://www.proquest.com/docview/2779523729 https://www.proquest.com/docview/2780070588 https://pubmed.ncbi.nlm.nih.gov/PMC9952102 https://doaj.org/article/9bcd0d9809804ff2b4742286f00fdf48
Volume	10
WOSCitedRecordID	wos000938390100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2306-5354 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001325264 issn: 2306-5354 databaseCode: DOA dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2306-5354 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001325264 issn: 2306-5354 databaseCode: M~E dateStart: 20140101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2306-5354 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001325264 issn: 2306-5354 databaseCode: M7P dateStart: 20140301 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Engineering Database customDbUrl: eissn: 2306-5354 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001325264 issn: 2306-5354 databaseCode: M7S dateStart: 20140301 isFulltext: true titleUrlDefault: http://search.proquest.com providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2306-5354 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001325264 issn: 2306-5354 databaseCode: BENPR dateStart: 20140301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2306-5354 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001325264 issn: 2306-5354 databaseCode: PIMPY dateStart: 20140301 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELbYXQ5w4P0ILJWRkDhFTePEsbmgLuqKPVBFdEHdU-QnRFqS0gdHfjszSfqIQHBAiiwlthNbM54ZT8bfEPLK8EhxxV0olDD4m9GFinkfZpI76wRXTNom2UQ2nYr5XOadw23VhVVuZWIjqG1t0Ec-jLNMwqYJbMG3i-8hZo3Cv6tdCo0jcoIoCawJ3cv3PhYWp6Dw24PBDHb3Q13Wbo_zh_CjeJS4p5Ma6P7fBfSBhupHTx6oo_O7_zuRe-ROZ4jSccs598kNVz0gtw_gCR8SNSu_lbDzpWl4BQuCzjYgV4AzaVnRRsd5DNOFe1XZ9oFaIM3p5fjzBc1bxNbVGzqmM3jftQvRleyWdA-v_Ih8Op9cvnsfdikZQgN23To0DCH6dCIts1kitRYskQysSGG5Sj1C5USRcZHTwkTcs5HPdOLsSEWxHjkh2GNyXNWVe0ooF9qrFPHtYp_oJNNpZDNpuOQ-1rHjAUm3RClMh1eOaTOuC9i3IDGLPxMzIMNdv0WL2PHPHmdI811rRNxuHtTLL0W3gAupjY2sFBFciYchJhmip3EfRd76RATkNXJMgXIBhmlUd7wBJosIW8UYmoOxKEdpQE57LWE9m371lm-KTp6sij3TBOTlrhp7Yoxc5eoNthEI3pQKGMuTlkV3U2JcxBKM8YBkPebtzblfU5VfG7RxCR8GK_TZ34f1nNyKwfxD51ScnJLj9XLjXpCb5se6XC0H5CibiwE5OZtM84-Dxu8xaJZqU86w_DmB-vziQ371C_B1SyI
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jj9MwFLaGAQk4sC-BAYwE4hTVzeLYSAiVZTTVDFWlFjRzCl4h0pCWLiD-FL-R95J0iUBwmgNSLont5Dl5q_P8PUKeGM4UV9yFQgmDvxldqGLvw0xyZ53gKpa2KjaRDQbi-FgOd8jP1V4YTKtc6cRKUduJwTXyTpRlEoIm8AVfTr-GWDUK_66uSmjUbHHofnyHkG3-ov8Gvu_TKNp_O359EDZVBUIDrskiNDGizOlE2thmidRaxImMwRESlqvUI9oLY8Yxp4Vh3Mddn-nE2a5ike46IWK47zlyHtyISFSpgsPNmk4cpeBg1BuR41iyji4mboMriHCnuHW5ZQOrUgG_G4Qti9jO1twyf_tX_7cXd41caRxt2qsl4zrZceUNcnkLfvEmUaPiSwGRPU3DEyCQjpagN0HyaFHSyoZ7TEOGc1Xa-oKaIk_Tce9Dnw5rRNr5c9qjI7jfqQtxqdzN6AY--hZ5fyZzvE12y0np7hLKhfYqRfy-yCc6yXTKbCYNl9xHOnI8IOmKCXLT4LFjWZDTHOIyZJ78z8wTkM563LRGJPnniFfIY-veiCheXZjMPuWNgsqlNpZZKRgciQcSkwzR4bhnzFufiIA8Qw7NUe8BmUY12zdgsogglvegOzjDspsGZK_VE_SVaTev-DRv9OU83zBpQB6vm3Ek5gCWbrLEPgLBqVIBtNypRWI9pZiLSEKwEZCsJSytObdbyuJzhaYu4cHgZd_7O1mPyMWD8buj_Kg_OLxPLkXg6uJCXJTskd3FbOkekAvm26KYzx5WKoGSj2ctSr8A8eGfaA
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bi9QwFA7rKqIP3i-jq0ZQfCqTado0EURG18VhZRiYVXafaq5aWDvjXBT_mr_Oc9rOpSj6tA9CX9ok7Ul7runJdwh5YgXTQgsfSS0t_mb0keYhRJkS3nkpNFeuKjaRDYfy-FiNdsjP1V4YTKtc6cRKUbuJxTXybpxlCoIm8AW7oUmLGO0fvJx-jbCCFP5pXZXTqFnk0P_4DuHb_MVgH7710zg-eHP0-m3UVBiILLgpi8hyRJwziXLcZYkyRvJEcXCKpBM6DYj8wpj1zBtpmQi8FzKTeNfTLDY9LyWH-54j5zMELa_SBkeb9R0ep-Bs1JuSOVesa4qJ32AMIvQpbmNu2cOqbMDvxmHLOrYzN7dM4cHV__klXiNXGgec9muJuU52fHmDXN6CZbxJ9Lj4UkDET9PoBAik4yXoU5BIWpS0su0B05PhXJeuvqCnyOv0qP9hQEc1Uu38Oe3TMdzv1Ee4hO5ndAMrfYu8P5M53ia75aT0dwkV0gSdIq5fHBKTZCZlLlNWKBFiE3vRIemKIXLb4LRjuZDTHOI1ZKT8z4zUId31uGmNVPLPEa-Q39a9EWm8ujCZfcobxZUrYx1zSjI4kgAkJhmixonAWHAhkR3yDLk1R30IZFrdbOuAySKyWN6H7uAkq17aIXutnqDHbLt5xbN5o0fn-YZhO-TxuhlHYm5g6SdL7CMRtCqVQMudWjzWU-JCxgqCkA7JWoLTmnO7pSw-VyjrCh4M3ve9v5P1iFwECcrfDYaH98mlGDxgXJ-Lkz2yu5gt_QNywX5bFPPZw0o7UPLxrCXpF6r7qCU
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Similar+5-Year+Survival+in+Transfemoral+and+Transapical+TAVI+Patients%3A+A+Single-Center+Experience&rft.jtitle=Bioengineering+%28Basel%29&rft.au=Mork%2C+Constantin&rft.au=Twerenbold%2C+Raphael&rft.au=Gahl%2C+Brigitta&rft.au=Eckstein%2C+Friedrich&rft.date=2023-01-24&rft.pub=MDPI+AG&rft.issn=2306-5354&rft.eissn=2306-5354&rft.volume=10&rft.issue=2&rft_id=info:doi/10.3390%2Fbioengineering10020156&rft.externalDocID=A742172915
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2306-5354&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2306-5354&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2306-5354&client=summon